X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (92) 92
male (66) 66
middle aged (64) 64
female (63) 63
adult (57) 57
gastroenterology & hepatology (48) 48
surgery (40) 40
transplantation (40) 40
index medicus (38) 38
liver transplantation (34) 34
aged (27) 27
article (18) 18
treatment outcome (18) 18
disease (17) 17
liver (17) 17
retrospective studies (17) 17
gastroenterology and hepatology (16) 16
adolescent (15) 15
prognosis (15) 15
hepatitis c (14) 14
time factors (14) 14
cirrhosis (13) 13
prospective studies (13) 13
survival (13) 13
risk factors (12) 12
hepatitis (11) 11
immunology (11) 11
infection (11) 11
recurrence (11) 11
severity of illness index (11) 11
survival analysis (11) 11
hepatology (10) 10
immunosuppression (10) 10
biopsy (9) 9
hepatitis c virus (9) 9
impact (9) 9
liver diseases (9) 9
liver transplantation - adverse effects (9) 9
recipients (9) 9
abridged index medicus (8) 8
graft survival (8) 8
liver - pathology (8) 8
liver failure (8) 8
liver transplantation - mortality (8) 8
medicine & public health (8) 8
survival rate (8) 8
united-states (8) 8
analysis (7) 7
cohort studies (7) 7
drug therapy, combination (7) 7
fibrosis (7) 7
fulminant hepatic-failure (7) 7
hepacivirus - immunology (7) 7
hepatitis c - surgery (7) 7
interferon-alpha - therapeutic use (7) 7
liver failure, acute - mortality (7) 7
model (7) 7
mortality (7) 7
united states (7) 7
virus-infection (7) 7
young adult (7) 7
antiviral agents - therapeutic use (6) 6
cholangitis, sclerosing - surgery (6) 6
expression (6) 6
gastroenterology (6) 6
genotype (6) 6
hepatitis c, chronic - immunology (6) 6
liver neoplasms - pathology (6) 6
liver neoplasms - surgery (6) 6
reoperation (6) 6
rna (6) 6
transplantation of organs, tissues, etc (6) 6
biomarkers - blood (5) 5
carcinoma, hepatocellular - pathology (5) 5
carcinoma, hepatocellular - therapy (5) 5
drug administration schedule (5) 5
experience (5) 5
follow-up studies (5) 5
health aspects (5) 5
hepacivirus - genetics (5) 5
hepatitis c - complications (5) 5
hepatocellular-carcinoma (5) 5
immunosuppressive agents - therapeutic use (5) 5
infections (5) 5
liver cirrhosis (5) 5
liver cirrhosis - virology (5) 5
liver failure, acute - diagnosis (5) 5
liver failure, acute - etiology (5) 5
liver neoplasms - mortality (5) 5
liver neoplasms - therapy (5) 5
meld (5) 5
patient selection (5) 5
prevalence (5) 5
rejection (5) 5
risk assessment (5) 5
therapy (5) 5
transplantation, homologous (5) 5
aged, 80 and over (4) 4
alanine transaminase - blood (4) 4
allografts (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e50826
Liver disease due to hepatitis C virus (HCV) infection is an important health problem worldwide. HCV induced changes in microRNAs (miRNA) are shown to mediate... 
TRANSCRIPTION FACTORS | FIBROSIS | C/EBP-ALPHA | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | CELL-CYCLE ARREST | INFECTION | MICRORNAS | HUMAN HEPATOCELLULAR-CARCINOMA | NF-KAPPA-B | EXPRESSION | Tumor Necrosis Factor-alpha - metabolism | Transcription, Genetic - drug effects | Humans | Middle Aged | Molecular Sequence Data | Male | MicroRNAs - metabolism | NF-kappa B - metabolism | Hepatocytes - metabolism | Promoter Regions, Genetic - genetics | Chitinase-3-Like Protein 1 | Inflammation - complications | Lectins - metabolism | Adipokines - genetics | Base Sequence | Adult | Female | Hepacivirus - physiology | Hepatitis C - complications | Liver Cirrhosis - genetics | Hepatocytes - drug effects | Biomarkers - metabolism | CCAAT-Enhancer-Binding Proteins - metabolism | Liver Cirrhosis - complications | Hepatitis C - genetics | Up-Regulation - genetics | Adipokines - metabolism | Signal Transduction - genetics | Receptor, Notch1 - metabolism | Down-Regulation - drug effects | Mutation - genetics | Down-Regulation - genetics | Up-Regulation - drug effects | Tumor Necrosis Factor-alpha - pharmacology | Signal Transduction - drug effects | Models, Biological | Hepatitis C - virology | Inflammation - genetics | Liver Cirrhosis - pathology | Lectins - genetics | MicroRNAs - genetics | Infection | MicroRNA | Analysis | Transplantation of organs, tissues, etc | Organ transplant recipients | Inflammation | Hepatitis C virus | Gene expression | Health aspects | Liver cirrhosis | Protein binding | Transcription factors | Transplants & implants | Transcription | Syngeneic grafts | Liver | Viruses | Infections | CCAAT/enhancer-binding protein | Hepatitis | Liver cancer | Signal transduction | Cell growth | Allografts | Rodents | Hepatology | Surgery | Cell cycle | Bioindicators | Localization | Deoxyribonucleic acid--DNA | Liver diseases | Cytokines | Nucleotide sequence | MiRNA | Tumor necrosis factor-α | Ribonucleic acid--RNA | Patients | Medicine | Signaling | Hepatocytes | Biopsy | MicroRNAs | Fibrosis | Regulatory mechanisms (biology) | Biomarkers | Notch protein | Hepatitis C | Prostate cancer | Binding sites | Viral infections | Liver transplantation | RNA | Deoxyribonucleic acid | Ribonucleic acid | DNA
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2013, Volume 8, Issue 8, p. e70744
Hepatitis C virus (HCV) induced liver disease is the leading indication for liver transplantation (LTx). Reinfection and accelerated development of fibrosis is... 
TGF-BETA | CIRRHOSIS | MULTIDISCIPLINARY SCIENCES | LIVER FIBROSIS | KINASE | POSTTRANSCRIPTIONAL GENE-REGULATION | HCV | GROWTH-FACTOR | MICRORNA EXPRESSION | REPRESSORS ZEB1 | PROGRESSION | Hepatitis C, Chronic - metabolism | Liver Cirrhosis - etiology | Gene Expression | Signal Transduction | Humans | Middle Aged | Protein Tyrosine Phosphatase, Non-Receptor Type 13 - metabolism | Gene Expression Regulation | Transcriptome | Male | MicroRNAs - metabolism | Hepatitis C, Chronic - complications | Gene Regulatory Networks | Transforming Growth Factor beta - biosynthesis | Transfection | RNA Interference | src-Family Kinases - metabolism | Adult | Female | Hepacivirus - physiology | MicroRNAs - genetics | Protein Tyrosine Phosphatase, Non-Receptor Type 13 - genetics | Enzyme Activation | Hepatitis C, Chronic - genetics | Tyrosine | Medical research | Phosphatases | Genes | Liver | Transplantation | B cells | Infection | MicroRNA | Analysis | Fibrosis | Medicine, Experimental | Fibroblast growth factors | Hepatitis C virus | Health aspects | Protein kinases | GTP-binding protein | Target recognition | Syngeneic grafts | Hormones | Phosphatase | Proteins | Cyclin-dependent kinase | Hepatitis | Liver cancer | Surgery | Fibroblasts | Physiology | Growth factors | Liver diseases | MiRNA | MAP kinase | Gene expression | Src protein | Patients | Polymerase chain reaction | Pathology | Protein phosphatase | Liver transplantation | Fibroblast growth factor | Transplants & implants | Viruses | Infections | Kinases | Allografts | Protein folding | Hepatology | Cell cycle | Extracellular matrix | Inflammation | Ribonucleic acid--RNA | Phospholipase C | Medicine | Phospholipase | Signaling | Cyclin-dependent kinase inhibitor p21 | Protein kinase | Biopsy | MicroRNAs | Collagen | Hepatitis C | Combinatorial analysis | Protein-tyrosine-phosphatase | RNA | Ribonucleic acid
Journal Article
Annals of the American Thoracic Society, ISSN 2325-6621, 06/2016, Volume 13, Issue 6, pp. 862 - 866
Journal Article
Annals of the American Thoracic Society, ISSN 2325-6621, 2016, Volume 13, Issue 8, pp. 1432 - 1433
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 05/2019, Volume 156, Issue 6, pp. S-1193 - S-1194
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 142, Issue 5, pp. S-946 - S-946
Journal Article
Hepatology, ISSN 0270-9139, 05/2014, Volume 59, Issue 5, pp. 2050 - 2052
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 10/2017, Volume 112, pp. S514 - S515
Journal Article
Journal of the American College of Surgeons, ISSN 1072-7515, 2008, Volume 207, Issue 6, pp. 847 - 852
Background Individuals greater than 60 years old donate an important portion of the organs available for orthotopic liver transplantation (OLT), but use of... 
Surgery | SURGERY | SINGLE-CENTER EXPERIENCE | IMPACT | RISK-FACTORS | HEPATITIS-C VIRUS | EXTENDED CRITERIA | OLDER | INFECTION | TERM | RECIPIENTS | Age Factors | Liver Transplantation - adverse effects | Humans | Middle Aged | Graft Survival | Liver Transplantation - mortality | Male | Living Donors | Young Adult | Adolescent | Adult | Female | Aged | Transplantation | Hepatitis C virus | Hepatitis C | Analysis | Patient outcomes | Liver
Journal Article